Heizaburo Yamamoto

A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer

Shinichiro Motohashi, Kaoru Nagato, Naoki Kunii et al. · The Journal of Immunology · 2009 · 229 citations

Life Sciences, Immunology, Oncology +17

The Interleukin-33-p38 Kinase Axis Confers Memory T Helper 2 Cell Pathogenicity in the Airway

Yusuke Endo, Kiyoshi Hirahara, Tomohisa Iinuma et al. · Immunity · 2015 · 226 citations

Life Sciences, Cell Biology, Immunology +12

Combination therapy of <i>in vitro</i>‐expanded natural killer T cells and α‐galactosylceramide‐pulsed antigen‐presenting cells in patients with recurrent head and neck carcinoma

Naoki Kunii, S. Horiguchi, Shinichiro Motohashi et al. · Cancer Science · 2009 · 183 citations · Full text

Medicine, Immunology, Oncology +17

Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer

Tetsuro Uchida, S. Horiguchi, Yuriko Tanaka et al. · Cancer Immunology Immunotherapy · 2007 · 165 citations · Full text

Life Sciences, Immunology, Oncology +10

Thy1 ⁺ IL-7 ⁺ lymphatic endothelial cells in iBALT provide a survival niche for memory T-helper cells in allergic airway inflammation

Kenta Shinoda, Kiyoshi Hirahara, Tomohisa Iinuma et al. · Proceedings of the National Academy of Sciences · 2016 · 121 citations · Full text

Life Sciences, Immunology, Pathology +17